Study Stopped
Research team no longer available.
Titration of PEEP During Mechanical Ventilation in Patients With ARDS Using Electrical Impedance Tomography.
1 other identifier
interventional
N/A
1 country
1
Brief Summary
Lung units that participate in gas exchange are known as 'recruited' lung. Patients with lung injury suffer from a proportion of units that do not participate in gas exchange (i.e. the derecruited lung), which results in impaired gas exchange and induces an inflammatory cascade. The level of PEEP is often coupled to indices of oxygenation such as PaO2, PaO2 to FIO2 ratio, or oxygen index. Currently, two strategies are widely accepted and considered equivocal, one strategy using a lower PEEP level coupled to a certain oxygen requirement, the other using a higher PEEP level. The primary purpose of this study is to demonstrate the safety and efficacy of an electrical impedance tomography (EIT) PEEP titration protocol designed to recruit collapsed lung in children with ARDS and properly maintain lung volumes by setting an optimal PEEP level. A safety system has been developed using the ARDSnet FIO2/PEEP High (upper threshold limit) and Low (lower threshold limit) algorithm. Efficacy will be defined as an improvement in lung volume as assessed by electrical impedance tomography, lung compliance and by an improvement in markers of gas exchange. Safety will be defined as the incidence of barotrauma and hemodynamic consequences that occur during the protocol. Those results will be compared to incidences of barotrauma and hemodynamic compromise within the ARDS literature. Knowledge gained from this pilot will be instrumental in developing an EIT imagine guided protocol which will allow us to conduct future RCTs utilizing EIT technology
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
Started Mar 2016
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 2, 2015
CompletedFirst Posted
Study publicly available on registry
November 4, 2015
CompletedStudy Start
First participant enrolled
March 1, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
July 1, 2020
CompletedJune 5, 2019
June 1, 2019
3.8 years
November 2, 2015
June 3, 2019
Conditions
Outcome Measures
Primary Outcomes (2)
Safety - measured by Barotrauma
3 days
Safety - measured by Gas Exchange
3 days
Study Arms (1)
EIT Guided PEEP Therapy
EXPERIMENTALInterventions
Electrical impedance tomography capitalizes on changes in electrical impendence between air-filled versus tissue or fluid-filled spaces in order to characterize and quantify regional distribution of lung volume at the bedside.
Eligibility Criteria
You may qualify if:
- a. The Berlin definition of ARDS36 i. Blood gas criteria:
- Mild: PaO2/FiO2 ratio of 201-300,
- Moderate: PaO2/FIO2 ratio of 101-200
- Severe: PaO2/FIO2 ratio of \< 100 ii. Acute onset (within 1 week) of bilateral (patchy, diffuse, or homogeneous) infiltrates consistent with pulmonary edema on chest radiograph, and iii. No evidence of left atrial hypertension
- \. Conventional lung protective mechanical ventilation Chest radiograph within the first 12h after the study recruitment
You may not qualify if:
- Meets the above criteria for ARDS for \> 72 hours
- \< 2 years of age or chest circumference \< 55 cm.
- Clinically recognized airways disease (e.g. anatomic or reactive airway disease by history, treatment or flow graphics)
- Uncuffed endotracheal tube in place
- Airleak
- Congenital heart disease
- Hemodynamically significant heart disease
- Congenital diaphragmatic hernia
- Pulmonary fibrosis
- Restrictive lung disease (other than ARDS)
- Cystic fibrosis
- Significant pulmonary hypertension requiring treatment (eg iNO, sildenafil, flolan)
- Severe brain injury with no intracranial pressure monitor or external ventricular drain in place
- Extra-corporeal life support
- Patients with unstable spinal injuries or diseases
- +8 more criteria
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Boston Children's Hospital
Boston, Massachusetts, 02115, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Co-Investigator
Study Record Dates
First Submitted
November 2, 2015
First Posted
November 4, 2015
Study Start
March 1, 2016
Primary Completion
December 1, 2019
Study Completion
July 1, 2020
Last Updated
June 5, 2019
Record last verified: 2019-06